
News|Articles|September 1, 2008
FDA Pipeline preview, September 2008
Recent FDA action (through September 2008) related to Immediate-release diclofenac capsules, tocilizumab, sugammadex, topical alprostadil cream, fospropofol, iloperidone, lacosamide, and vascular endothelial growth factor b.
Advertisement
Approvable designations
Recommended for approval
Nonapprovable designations
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
PBM reform. It has finally happened
3
FDA issues draft guidance on MRD and complete response as primary endpoints for accelerated multiple myeloma drug approvals
4
TrumpRx launches; some experts question its long-term value
5

























